AU2002351655A1 - Device for release of a drug containing oseltamivir and a h1 antagonist - Google Patents

Device for release of a drug containing oseltamivir and a h1 antagonist

Info

Publication number
AU2002351655A1
AU2002351655A1 AU2002351655A AU2002351655A AU2002351655A1 AU 2002351655 A1 AU2002351655 A1 AU 2002351655A1 AU 2002351655 A AU2002351655 A AU 2002351655A AU 2002351655 A AU2002351655 A AU 2002351655A AU 2002351655 A1 AU2002351655 A1 AU 2002351655A1
Authority
AU
Australia
Prior art keywords
antagonist
release
drug containing
containing oseltamivir
oseltamivir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351655A
Inventor
Joaquina Faour
Juan A. Vergez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osmotica Corp
Original Assignee
Osmotica Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osmotica Corp filed Critical Osmotica Corp
Publication of AU2002351655A1 publication Critical patent/AU2002351655A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
AU2002351655A 2002-08-29 2002-08-29 Device for release of a drug containing oseltamivir and a h1 antagonist Abandoned AU2002351655A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CR2002/000005 WO2004019917A1 (en) 2002-08-29 2002-08-29 Device for release of a drug containing oseltamivir and a h1 antagonist

Publications (1)

Publication Number Publication Date
AU2002351655A1 true AU2002351655A1 (en) 2004-03-19

Family

ID=31954586

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351655A Abandoned AU2002351655A1 (en) 2002-08-29 2002-08-29 Device for release of a drug containing oseltamivir and a h1 antagonist

Country Status (2)

Country Link
AU (1) AU2002351655A1 (en)
WO (1) WO2004019917A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104367558A (en) * 2013-08-15 2015-02-25 北京星昊医药股份有限公司 Oseltamivir lyophilized orally-disintegrating tablets and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US6605302B2 (en) * 2001-07-17 2003-08-12 Osmotica Corp. Drug delivery device containing oseltamivir and an H1 antagonist

Also Published As

Publication number Publication date
WO2004019917A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
HK1254279A1 (en) Pharmaceutical preparation containing oxycodone and naloxone
AU2003268015A1 (en) Packaging and dispensing of rapid dissolve dosage form
AU2003274985A1 (en) Dispenser components and methods for infusion device
AU2003261214A1 (en) Use of printing and other technology for micro-component placement
IL162870A0 (en) Controlled release pharmaceutical dosage forms of a cholesteryl estertransfer protein inhibitor
IL166772A0 (en) Pharmaceuticals formulations and methods for modified release of statin drugs
AU2003243632A1 (en) Processes for forming dental materials and device
GB0521686D0 (en) Medicament delivery device and a method of medicament delivery
AU2003218457A1 (en) Method and device for intradermally delivering a substance
PL373914A1 (en) Immediate release dosage forms containing solid drug dispersions
AU2003246514A1 (en) Dosage display device
AU2002361742A1 (en) Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist
AU2002217373A1 (en) Controlled release pharmaceutical formulation containing venlafaxine
AU2003245305A1 (en) Pill dispensing apparatus and system
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
AU2003242784A1 (en) Method and device for dispensing individual doses of a radiopharmaceutical solution
AU2003212647A1 (en) Secure device for preventing unauthorised use of distributed content
AU2003240654A1 (en) Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
AU2003243439A1 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
AU2003260239A1 (en) Solid dosage forms for rapid dissolution of poorly soluble drugs
AU2003296628A1 (en) Agent with a retarded release of substances
AU2002351655A1 (en) Device for release of a drug containing oseltamivir and a h1 antagonist
AU2003279162A1 (en) Device for destruction of frangible items
AU2002367117A1 (en) A medicine dispensing system and components thereof
AU2003201620A1 (en) Container for doses and reminder device for administration of doses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase